BioCentury | Aug 3, 2015
Product Development

Vax populi

...right orientation to have the right epitopes exposed to generate neutralizing antibodies. Then Swiss company Redvax GmbH...
...neutralizing antibodies that neutralizes CMV entry in a number of different cell types." Pfizer acquired Redvax...
BioCentury | Jul 22, 2015
Company News

Pfizer details new focus on maternal vaccines

...RSV); and a third focused on cytomegalovirus (CMV) that came from Pfizer's January acquisition of Redvax GmbH...
Items per page:
1 - 2 of 2
BioCentury | Aug 3, 2015
Product Development

Vax populi

...right orientation to have the right epitopes exposed to generate neutralizing antibodies. Then Swiss company Redvax GmbH...
...neutralizing antibodies that neutralizes CMV entry in a number of different cell types." Pfizer acquired Redvax...
BioCentury | Jul 22, 2015
Company News

Pfizer details new focus on maternal vaccines

...RSV); and a third focused on cytomegalovirus (CMV) that came from Pfizer's January acquisition of Redvax GmbH...
Items per page:
1 - 2 of 2